Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-16 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 500 | $16.33 - $16.33 | $8,164 |
| 2024-09-16 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 500 | $6.49 - $6.49 | $3,245 |
| 2024-08-19 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 500 | $15.00 - $15.00 | $7,500 |
| 2024-08-19 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 500 | $6.49 - $6.49 | $3,245 |
| 2024-07-16 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 1750 | $27.11 - $27.11 | $47,442 |
| 2024-07-16 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 1750 | $6.49 - $8.04 | $13,294 |
| 2024-07-11 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 1996 | $25.00 - $25.00 | $49,900 |
| 2024-07-11 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 1996 | $15.78 - $15.78 | $31,496 |
| 2024-07-10 | 4D Molecular Therapeutics, Inc. | Kirn David
(Chief Executive Officer) |
S | Common Stock | D | 12923 | $22.49 - $22.49 | $290,598 |
| 2024-07-10 | 4D Molecular Therapeutics, Inc. | Kirn David
(Chief Executive Officer) |
M | Common Stock | A | 12923 | $14.42 - $15.78 | $188,076 |
| 2024-07-01 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 4248 | $21.36 - $21.36 | $90,757 |
| 2024-07-01 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 4248 | $6.49 - $8.04 | $32,088 |
| 2024-06-24 | 4D Molecular Therapeutics, Inc. | Kirn David
(Chief Executive Officer) |
S | Common Stock | D | 12930 | $23.10 - $23.10 | $298,711 |
| 2024-06-24 | 4D Molecular Therapeutics, Inc. | Kirn David
(Chief Executive Officer) |
M | Common Stock | A | 12930 | $14.42 - $14.42 | $186,450 |
| 2024-06-17 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
S | Common Stock | D | 1750 | $23.71 - $23.71 | $41,493 |
| 2024-06-17 | 4D Molecular Therapeutics, Inc. | Bizily Scott
(Chief Legal Officer) |
M | Common Stock | A | 1750 | $6.49 - $8.04 | $13,294 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |